↓ Skip to main content

PARP inhibitors as potential therapeutic agents for various cancers: focus on niraparib and its first global approval for maintenance therapy of gynecologic cancers

Overview of attention for article published in Gynecologic Oncology Research and Practice, November 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PARP inhibitors as potential therapeutic agents for various cancers: focus on niraparib and its first global approval for maintenance therapy of gynecologic cancers
Published in
Gynecologic Oncology Research and Practice, November 2017
DOI 10.1186/s40661-017-0055-8
Pubmed ID
Authors

Mekonnen Sisay, Dumessa Edessa

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 73 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 19 26%
Student > Ph. D. Student 11 15%
Student > Master 9 12%
Student > Doctoral Student 4 5%
Other 4 5%
Other 13 18%
Unknown 13 18%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 17 23%
Medicine and Dentistry 16 22%
Pharmacology, Toxicology and Pharmaceutical Science 8 11%
Chemistry 4 5%
Agricultural and Biological Sciences 3 4%
Other 8 11%
Unknown 17 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 May 2022.
All research outputs
#4,291,863
of 23,312,088 outputs
Outputs from Gynecologic Oncology Research and Practice
#9
of 34 outputs
Outputs of similar age
#91,048
of 440,169 outputs
Outputs of similar age from Gynecologic Oncology Research and Practice
#1
of 6 outputs
Altmetric has tracked 23,312,088 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 34 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.1. This one scored the same or higher as 25 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,169 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them